CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches version 2 of TrialConsent, offering new enhancements to the industry’s first electronic informed consent solution with a fully embedded design tool.
The solution promotes better comprehension, compliance and retention rates while reducing regulatory risk. TrialConsent 2.0 marks a significant advance in electronic informed consent by offering an improved user interface with enhanced navigation for participants and site personnel. Sponsors, Institutional Review Boards, Ethics Committees and research sites also benefit from the improved collaboration offered by the solution and much simplified review process.
Rachael Wyllie, CEO commented, “CRF Health is committed to simplifying the path to approval, streamlining complex processes and delivering reliable results for superior clinical trial outcomes. The forward-thinking architecture behind TrialConsent 2.0 allows the platform to be fully integrated with an existing eCOA solution or delivered as a stand-alone solution, simplifying and providing consistency, control and flexibility to the informed consent process. Comprehensive reporting enables study teams and ethics committees to monitor the consent status of sites and participants, track and analyze compliance and ultimately make smarter decisions. We firmly believe this advancement represents a step change in the way Informed Consent can be managed throughout its lifecycle.”